Navigation Links
LCA-Vision Announces Consent Solicitation Deadline; Urges Stockholders to Return Gold Consent Revocation Card

CINCINNATI, Feb. 11 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV) today announced that it has received an executed written consent from Craig Joffe dated February 9, 2009. Based on the date of this consent, the expiration date of the consent solicitation will be April 9, 2009. The Company will issue another press release if it receives an earlier dated executed written consent.

LCA-Vision filed its Definitive Consent Revocation Statement ("Consent Revocation Statement") with the Securities and Exchange Commission on Monday, February 9, 2009, and copies of the Consent Revocation Statement with a GOLD Consent Revocation Card were mailed to stockholders beginning February 10, 2009. The Consent Revocation Statement can be obtained immediately from the SEC's website at the following link:

c14a.htm (due to length of url, please copy and paste into browser)

or from the Investor Relations section of the Company's website at and Copies of the Consent Revocation Statement and consent revocation card may also be obtained from Georgeson Inc.

The Board of Directors of LCA-Vision has determined that the consent solicitation of the Joffe Group, proposing, among other things, to remove, without cause the directors that you elected at the 2008 annual meeting of stockholders, and replace them with a slate of nominees selected by the Joffe Group, is not in the best interests of LCA-Vision or its stockholders, and urges LCA-Vision stockholders to reject the Joffe Group's proposals.

Stockholders should not sign the Joffe Group's White consent card. If you have previously signed a White consent card, you may revoke that consent. The Board of Directors is mailing to LCA-Vision stockholders a GOLD consent revocation card that they should immediately sign, date and mail back. Stockholders may support their current board and management by signing, dating and mailing the GOLD consent revocation card as soon as they receive it.

Additional Information:

Georgeson Inc. has been retained by LCA-Vision as consent revocation solicitation agent. Stockholders with questions are encouraged to call them toll-free 1-800-457-0109. Copies of the Company's Consent Revocation Statement and any other documents filed by LCA-Vision with the SEC in connection with the consent solicitation can be obtained free of charge from the SEC's website at, from the Company's website at and, or from Georgeson.

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 75 LasikPlus(R) fixed-site laser vision correction centers in 32 states and 57 markets in the United States and a joint venture in Canada. Additional company information is available at and

    Earning Trust Every Moment.
                                  Transforming Lives Every Day.

    For Additional Information

    Company Contact:                    Investor Relations Contact:
    Barb Kise                           Jody Cain
    LCA-Vision Inc.                     Lippert/Heilshorn & Associates
    513-792-9292                        310-691-7100

SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results
2. LCA-Visions National Lasik Network Named as U.S. Provider for National Vision Administrators
3. The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders
4. LCA-Vision to Hold Corporate Update Conference Call and Q&A Session on February 6
5. LCA-Vision to Announce Fourth Quarter and Full Year 2008 Financial Results on Tuesday, February 10, 2009
6. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
7. LCA-Vision Urges Stockholders to Take No Action Regarding the Joffe Groups Threatened Consent Solicitation
8. LCA-Visions Former Executive Management Team Sends Open Letter to LCA-Vision Stockholders
9. LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group
10. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill
11. 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
Post Your Comments:
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released ... failing their residents by lacking a comprehensive, proven plan to eliminate ... a definitive ranking of how states are tackling the worst drug ... only four states – Kentucky , ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: